Showing results (101-110 of 188) with videos related to
Sort By:
Pageof 19
BMC Pulmonary Medicine|March 26, 2013
RECODE: design and baseline results of a cluster randomized trial on cost-effectiveness of integrated COPD management in primary careAnnemarije L Kruis, Melinde R S Boland, Catharina H Schoonvelde, et al.Alimentary Pharmacology & Therapeutics|April 18, 2018
High body mass index is associated with increased risk of treatment failure and surgery in biologic-treated patients with ulcerative colitisS Kurnool, N H Nguyen, J Proudfoot, et al.AIDS Patient Care and Stds|May 6, 2009
Delivery of an HIV prevention counseling program in an infectious diseases clinic: implementation process and lessons learnedShilpa N Patel, Carol E Golin, Gary Marks, et al.Proceedings of the National Academy of Sciences of the United States of America|September 26, 2020
Delineation of a molecularly distinct terminally differentiated memory CD8 T cell populationJ Justin Milner, Hongtuyet Nguyen, Kyla Omilusik, et al.Science (New York, N.Y.)|December 13, 2016
Sensitive electromechanical sensors using viscoelastic graphene-polymer nanocompositesConor S Boland, Umar Khan, Gavin Ryan, et al.Child Abuse & Neglect|November 7, 2025
Changes in child maltreatment occurrence during the COVID-19 pandemic: A systematic reviewVanessa De Rubeis, Lil Tonmyr, Sholeh Rahman, et al.BMJ Open|November 4, 2015
Cost-effectiveness of integrated COPD care: the RECODE cluster randomised trialMelinde R S Boland, Annemarije L Kruis, Apostolos Tsiachristas, et al.Journal of the American Chemical Society|August 27, 2009
Trends in covalency for d- and f-element metallocene dichlorides identified using chlorine K-edge X-ray absorption spectroscopy and time-dependent density functional theoryStosh A Kozimor, Ping Yang, Enrique R Batista, et al.Pharmaceutics|March 29, 2023
The ClC-2 Chloride Channel Activator, Lubiprostone, Improves Intestinal Barrier Function in Biopsies from Crohn's Disease but Not Ulcerative Colitis PatientsYoung Su Park, Sang Bum Kang, Ronald R Marchelletta, et al.Inflammatory Bowel Diseases|May 26, 2023
Responsiveness to Vedolizumab Therapy in Ulcerative Colitis is Associated With Alterations in Immune Cell-Cell CommunicationsPaul Hsu, Eunice J Choi, Shefali A Patel, et al.Pageof 19